We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
DASA funding and support has accelerated South West based SME Cervus’s innovative training tool
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices
Novartis Pharmaceuticals UK are recalling a batch of Sandimmun Oral Solution due to the presence of crystals in the solution.
Minister Nigel Adams explored family links to pottery in Stoke-on-Trent and promoted the Cultural Development Fund
First published during the 2019 to 2022 Johnson Conservative government
The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years.
The CMA has opened an investigation into suspected anti-competitive practices in the supply of drugs used to treat bipolar disorder.
Details of a Product defect recall for Clavudale 40 mg/10 mg tablets for cats and dogs
Decision for applicant Clarins Fragrance Group against registration number NI648184, applicant successful.
Dstl's miniaturised space weather instrumentation suite will be aboard Virgin Orbit which is aiming to launch from Spaceport Cornwall later in 2022.
The CMA has completed its investigation into anti-competitive agreements in the pharmaceutical sector under Chapter I CA98 (case reference: 50511-2).
The CMA is consulting on proposed commitments from Essential Pharma to keep a key bipolar drug on the market, and ensure it is affordable to the NHS.
Information about someone’s violent or abusive behaviour will be disclosed faster under changes to Clare’s Law proposed by the Home Office today (7 May).
Consilient Health UK Ltd is recalling a specific batch due to limited units from the batch being distributed prior to batch release.
A summary of letters and recent medicine recalls and notifications sent to healthcare professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).